ASPIRIN-EXACERBATED RESPIRATORY DISEASE
Clinical trials for ASPIRIN-EXACERBATED RESPIRATORY DISEASE explained in plain language.
Never miss a new study
Get alerted when new ASPIRIN-EXACERBATED RESPIRATORY DISEASE trials appear
Sign up with your email to follow new studies for ASPIRIN-EXACERBATED RESPIRATORY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tests Dupilumab's impact on aspirin sensitivity in AERD patients
Knowledge-focused CompletedThis study looked at how dupilumab, a drug for asthma and nasal polyps, changes reactions to aspirin in people with Aspirin-Exacerbated Respiratory Disease (AERD). Sixteen adults already taking dupilumab for at least 12 weeks underwent an aspirin challenge to see if they had fewe…
Matched conditions: ASPIRIN-EXACERBATED RESPIRATORY DISEASE
Phase: PHASE2 • Sponsor: Scripps Clinic • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC
-
Scientists probe immune culprit behind stubborn nasal polyps
Knowledge-focused CompletedThis study looked at how a protein called IL-5 affects different cells in the sinuses of people with nasal polyps and aspirin-exacerbated respiratory disease. Researchers analyzed tissue samples from 30 participants to understand how IL-5 contributes to immune problems. The goal …
Matched conditions: ASPIRIN-EXACERBATED RESPIRATORY DISEASE
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 06, 2026 16:03 UTC